"This award will help fund NiTech Solutions' innovative research and development programme and fits with Scottish Enterprise's objective of supporting innovative businesses in growing and competitive global sectors, particularly where commercialised research meets global industry demand." "The award is recognition of the efforts and advances being made by SMEs operating within the sector. Industry body Chemical Sciences Scotland played a key role in helping NiTech apply for the funding.Ĭaroline Strain, head of Chemical Sciences at Scottish Enterprise, said:"This is a fantastic achievement for NiTech Solutions and is a first for the chemical sciences sector in Scotland. NiTech is a spin-out from Heriot-Watt University which was founded by Professor Xiong-Wei Ni.Ĭurrent clients include AstraZeneca, GSK, Pfizer and Johnson and Johnson. "This would give the companies operating in the health sector the tools to reduce costs and drive innovation." Additionally, smaller economic production quantities are critical in moving towards "personalised medicines".
#Tsb east kilbride how to#
Governments and individuals do not want to pay such high costs so the question is how to get some of the costs of manufacturing down? "By advancing smaller scale processing technology, the cost of plant, buildings, energy, waste and utilities is reduced resulting in lower manufacturing cost. "One of the biggest issues with drug development is cost. "The research we are undertaking could, ultimately, revolutionise drug manufacture and play a key part in achieving lower costs and more sustainable methods of manufacture.
"This could open up a new business stream for us in bio-related therapeutics which we currently don't access. "We are working with Genzyme with one of their key compounds to see whether we can manufacture it better.
Ian Laird, managing director of NiTech, said: "This is a feasibility study round about biotechnology, which is a growing area of interest because of the therapeutic benefits. The East Kilbride company, which employs 15 people, is partnering with global player Genzyme on the six-month study. NiTech Solutions is using the grant from the Technology Strategy Board (TSB) to support research into new processing methods for drugs and explore opportunities in biomanufacturing. A chemical sciences company has won £175,000 funding for a project it is leading.
0 kommentar(er)
